Samuel Agyapong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samuel Agyapong has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Bhuvan Majmudar
Egality Health Ltd., London, UK
2 shared publications - Catherine Henshall
Oxford School of Nursing and Midwifery, Oxford Brookes University, Oxford, UK
2 shared publications - Clair Merriman
Oxford University Hospitals NHS Foundation Trust Oxford UK
2 shared publications - Georgia Clancy
Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK
2 shared publications - Naomi Thorpe
Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK
2 shared publications - Shireen Patel
University of Nottingham, Nottingham, UK
2 shared publications
Latest Publications
- Open Access
Context-dependent effects of ketamine on emotional evidence integration
Understanding others’ emotions requires continuously integrating noisy affective information as emotional states change over time. Research on emotion processing, however, has thus far focused on static environments or discrete events. Here, we developed a continuous emotional evidence integration task in which participants had to track the average emotional state in a rapidly changing sequence of faces under different levels of environmental volatility. This allowed us to examine emotion integration in changing environments. In online (n=92) and in-person (n=29) cohorts, participants integrated emotional information over longer timescales in stable environments while relying more strongly on recent evidence under volatility, consistent with principles established in perceptual decision-making. We further examined whether this process was modulated by ketamine, an NMDA receptor antagonist associated with evidence integration in the perceptual domain. We conducted a double-blind, placebo-controlled, within-subject study and probed emotion integration during the post-acute period, approximately 1.5 hours after the infusion. Ketamine modulated the temporal weighting of emotional evidence, shifting the balance between recent and past information depending on environmental volatility. Together, these findings show that emotional evidence integration dynamically adapts to the statistical structure of the environment and that ketamine can further modulate this process, which may have relevance for affective disorders.
Open AccessContext-dependent effects of ketamine on emotional evidence integration
Understanding others’ emotions requires continuously integrating noisy affective information as emotional states change over time. Research on emotion processing, however, has thus far focused on static environments or discrete events. Here, we developed a continuous emotional evidence integration task in which participants had to track the average emotional state in a rapidly changing sequence of faces under different levels of environmental volatility. This allowed us to examine emotion integration in changing environments. In online (n=92) and in-person (n=29) cohorts, participants integrated emotional information over longer timescales in stable environments while relying more strongly on recent evidence under volatility, consistent with principles established in perceptual decision-making. We further examined whether this process was modulated by ketamine, an NMDA receptor antagonist associated with evidence integration in the perceptual domain. We conducted a double-blind, placebo-controlled, within-subject study and probed emotion integration during the post-acute period, approximately 1.5 hours after the infusion. Ketamine modulated the temporal weighting of emotional evidence, shifting the balance between recent and past information depending on environmental volatility. Together, these findings show that emotional evidence integration dynamically adapts to the statistical structure of the environment and that ketamine can further modulate this process, which may have relevance for affective disorders.
- Open Access
- 21 July 2026
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
A systematic review and meta synthesis of barriers and facilitators to Black women’s participation in healthcare research
Background: Black women are under-represented in clinical research, contributing to persistent health inequities and undermining the validity and generalisability of research findings. Understanding facilitators and barriers to their research engagement is essential to addressing these challenges. This study aimed to identify and synthesise evidence on barriers and facilitators which influence Black women’s participation in healthcare research, to inform inclusive recruitment strategies and equitable research designs. Methods: This systematic review was conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD42024587308). Findings were narratively synthesised using thematic analysis and discussed iteratively through Patient and Public Involvement. Five databases were searched (CINAHL, PsycInfo, Embase, MIDIRS, MEDLINE) for studies published since 2010. Papers in any language were screened for inclusion. Patient and Public Involvement members informed review objectives and data interpretation. Primary research studies reporting on Black women’s experiences, attitudes, and facilitators/barriers to participating in any type of healthcare research. Studies were included if ≥ 50% (to ensure primary representation) of the sample recruited were Black women. Results: Seventy-two studies were included. Most were from America and spanned research areas relating to oncology, Human Immunodeficiency Virus (HIV), dementia, maternity, and general health. Five overarching themes identified how Black women’s participation in healthcare research is shaped by a complexity of factors. These were mistrust , interpersonal experiences, altruism, self-interest, and low health/research literacy and awareness . Patient and Public Involvement consultations concurred that the findings aligned with a “bridge and barriers” analogy, illustrating how various factors can facilitate or prevent Black women from engaging with research opportunities. This provided a clear framework to guide culturally sensitive implementation for researchers, healthcare professionals, and policymakers. Conclusions: Inclusive strategies for recruiting Black women into research must focus on co-constructing a bridge between communities and research systems. This requires structural and systemic change in research delivery environments and ongoing collaborations with all stakeholders including Black women, healthcare system providers, and research teams. Trial registration: PROSPERO (CRD42024587308).
- 21 July 2026
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
Open AccessA systematic review and meta synthesis of barriers and facilitators to Black women’s participation in healthcare research
Background: Black women are under-represented in clinical research, contributing to persistent health inequities and undermining the validity and generalisability of research findings. Understanding facilitators and barriers to their research engagement is essential to addressing these challenges. This study aimed to identify and synthesise evidence on barriers and facilitators which influence Black women’s participation in healthcare research, to inform inclusive recruitment strategies and equitable research designs. Methods: This systematic review was conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD42024587308). Findings were narratively synthesised using thematic analysis and discussed iteratively through Patient and Public Involvement. Five databases were searched (CINAHL, PsycInfo, Embase, MIDIRS, MEDLINE) for studies published since 2010. Papers in any language were screened for inclusion. Patient and Public Involvement members informed review objectives and data interpretation. Primary research studies reporting on Black women’s experiences, attitudes, and facilitators/barriers to participating in any type of healthcare research. Studies were included if ≥ 50% (to ensure primary representation) of the sample recruited were Black women. Results: Seventy-two studies were included. Most were from America and spanned research areas relating to oncology, Human Immunodeficiency Virus (HIV), dementia, maternity, and general health. Five overarching themes identified how Black women’s participation in healthcare research is shaped by a complexity of factors. These were mistrust , interpersonal experiences, altruism, self-interest, and low health/research literacy and awareness . Patient and Public Involvement consultations concurred that the findings aligned with a “bridge and barriers” analogy, illustrating how various factors can facilitate or prevent Black women from engaging with research opportunities. This provided a clear framework to guide culturally sensitive implementation for researchers, healthcare professionals, and policymakers. Conclusions: Inclusive strategies for recruiting Black women into research must focus on co-constructing a bridge between communities and research systems. This requires structural and systemic change in research delivery environments and ongoing collaborations with all stakeholders including Black women, healthcare system providers, and research teams. Trial registration: PROSPERO (CRD42024587308).
- Open Access
- 30 January 2026
- Published by Springer Nature in Research Square
A Systematic Review and Meta-Synthesis to Explore the Barriers and Facilitators to Black Women’s Participation in Healthcare Research
Background: Black women are under-represented in clinical research, contributing to persistent health disparities and undermining the validity and generalisability of research findings. Understanding facilitators and barriers to their research engagement is essential to addressing these challenges. Objective: To identify and synthesise evidence on barriers and facilitators which influence Black women’s participation in healthcare research, to inform inclusive recruitment strategies and equitable research designs. Design: This systematic review was conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD42024587308). Findings were narratively synthesised using thematic analysis and discussed iteratively through Patient and Public Involvement. consultations. Data Sources: Five databases were searched (CINAHL, PsycInfo, Embase, MIDIRS, MEDLINE) for studies published since 2010. Papers in any language were screened for inclusion. Patient and Public Involvement members informed review objectives and data interpretation. Eligibility Criteria: Primary research studies reporting on Black women’s experiences, attitudes, and facilitators/barriers to participating in any type of healthcare research. Studies were included if ≥50% of the sample recruited were Black women. Results: Sixty-nine studies were included. Most were from America and spanned research areas relating to oncology, Human Immunodeficiency Virus (HIV), dementia, maternity, and general health. Five overarching themes identified how Black women’s participation in healthcare research is shaped by a complexity of factors. These were mistrust , interpersonal experiences, altruism, self-interest, and low health/research literacy and awareness . Patient and Public Involvement consultations concurred that the findings aligned with a “bridge and barriers” analogy, illustrating how various factors can facilitate or prevent Black women from engaging with research opportunities. This provided a clear framework to guide culturally sensitive implementation for researchers, healthcare professionals, and policymakers. Conclusions: Inclusive strategies for recruiting Black women into research must focus on co-constructing a bridge between communities and research systems. This requires structural and systemic change in research delivery environments and ongoing collaborations with all stakeholders including Black women, healthcare system providers, and research teams. Systematic review registration: PROSPERO (CRD42024587308).
- 30 January 2026
- Published by Springer Nature in Research Square
Open AccessA Systematic Review and Meta-Synthesis to Explore the Barriers and Facilitators to Black Women’s Participation in Healthcare Research
Background: Black women are under-represented in clinical research, contributing to persistent health disparities and undermining the validity and generalisability of research findings. Understanding facilitators and barriers to their research engagement is essential to addressing these challenges. Objective: To identify and synthesise evidence on barriers and facilitators which influence Black women’s participation in healthcare research, to inform inclusive recruitment strategies and equitable research designs. Design: This systematic review was conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD42024587308). Findings were narratively synthesised using thematic analysis and discussed iteratively through Patient and Public Involvement. consultations. Data Sources: Five databases were searched (CINAHL, PsycInfo, Embase, MIDIRS, MEDLINE) for studies published since 2010. Papers in any language were screened for inclusion. Patient and Public Involvement members informed review objectives and data interpretation. Eligibility Criteria: Primary research studies reporting on Black women’s experiences, attitudes, and facilitators/barriers to participating in any type of healthcare research. Studies were included if ≥50% of the sample recruited were Black women. Results: Sixty-nine studies were included. Most were from America and spanned research areas relating to oncology, Human Immunodeficiency Virus (HIV), dementia, maternity, and general health. Five overarching themes identified how Black women’s participation in healthcare research is shaped by a complexity of factors. These were mistrust , interpersonal experiences, altruism, self-interest, and low health/research literacy and awareness . Patient and Public Involvement consultations concurred that the findings aligned with a “bridge and barriers” analogy, illustrating how various factors can facilitate or prevent Black women from engaging with research opportunities. This provided a clear framework to guide culturally sensitive implementation for researchers, healthcare professionals, and policymakers. Conclusions: Inclusive strategies for recruiting Black women into research must focus on co-constructing a bridge between communities and research systems. This requires structural and systemic change in research delivery environments and ongoing collaborations with all stakeholders including Black women, healthcare system providers, and research teams. Systematic review registration: PROSPERO (CRD42024587308).